Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Octreotide |
Is a |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatostatin-14 |
Is a |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatostatin-28 |
Is a |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatostatin measurement (procedure) |
Has measured component |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatostatin antigen |
Direct substance |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Serum somatostatin measurement (procedure) |
Has measured component |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatostatin measurement (procedure) |
Component |
True |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum somatostatin measurement (procedure) |
Component |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lanreotide 30mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide acetate 38mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Plasma somatostatin level (procedure) |
Component |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing somatostatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Somatostatin analogue-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 50micrograms/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 100micrograms/1mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 500micrograms/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 1mg/5mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 10mg depot injection+solvent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 20mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 30mg depot injection+solvent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing octreotide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide 60mg/0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide 90mg/0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide 120mg/0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 20mg depot injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 10mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 30mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 1mg/mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 100mcg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 200mcg/mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 500mcg/mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 50mcg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide acetate 30mg/vial injection suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 1mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 1mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing octreotide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lanreotide 30mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatostatin analogue-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatostatin acetate |
Is a |
False |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatostatin acetate |
Is modification of (attribute) |
True |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatostatin-28 |
Is modification of (attribute) |
True |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Somatostatin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Plasma somatostatin level (procedure) |
Component |
True |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum somatostatin measurement (procedure) |
Component |
True |
Somatostatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |